Clinical implications of stopping nevirapine-based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistance.
about
Randomized, controlled trial of therapy interruption in chronic HIV-1 infectionCD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials.In vitro resistance profile of the candidate HIV-1 microbicide drug dapivirineA comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy.Virological failure of staggered and simultaneous treatment interruption in HIV patients who began Efavirenz-based regimens after allergic reactions to nevirapine.Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to preventionModifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi.Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study.Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.Predictors of antiretroviral treatment-associated tuberculosis in Ethiopia: a nested case-control study.Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV.
P2860
Q24809608-D396CE9E-53CE-428A-B0BC-2D5838462FDEQ35562938-2BEC4311-A31C-4AF7-B4B1-92195CEEC31CQ35689311-77DCA417-BB1A-4922-9EA9-AD4AEAA828A0Q35827891-EE0581DE-E4B6-48FC-92D1-15314D944E39Q36621432-BAD928EA-7BE6-485E-8917-1FF45958F373Q37071435-D1F36E0E-23ED-45AF-9B4D-0733EE9FA830Q37464854-E310D45F-0D82-4A91-932A-A4440C538000Q37503472-204D50B7-883E-450C-947E-EBB7D1EDC5EEQ37979697-B23602B8-1DD4-4E7E-9634-F124864DD299Q41926207-1027CB17-0CAD-47A4-A775-C17CB5F25F8BQ45329190-BD2B1E43-450E-4655-8097-E5921D126719Q53850313-1F9196BC-DDB6-4BD0-8C50-ECF7CF863EAB
P2860
Clinical implications of stopping nevirapine-based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistance.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Clinical implications of stopp ...... avoidance of drug resistance.
@en
Clinical implications of stopp ...... avoidance of drug resistance.
@nl
type
label
Clinical implications of stopp ...... avoidance of drug resistance.
@en
Clinical implications of stopp ...... avoidance of drug resistance.
@nl
prefLabel
Clinical implications of stopp ...... avoidance of drug resistance.
@en
Clinical implications of stopp ...... avoidance of drug resistance.
@nl
P2093
P2860
P1433
P1476
Clinical implications of stopp ...... avoidance of drug resistance.
@en
P2093
G P Taylor
J R Clarke
N E Mackie
P2860
P304
P356
10.1111/J.1468-1293.2004.00208.X
P577
2004-05-01T00:00:00Z